SUVRETTA CAPITAL MANAGEMENT, LLC - Mar 26, 2025 Form SCHEDULE 13D/A Schedule Report for Benitec Biopharma Inc. (BNTC)

Filing Manager
SUVRETTA CAPITAL MANAGEMENT, LLC
Reporting Manager
SUVRETTA CAPITAL MANAGEMENT, LLC
Security
Benitec Biopharma Inc. Common Stock, par value $0.0001
Symbol
BNTC
Shares outstanding
31.3M shares
Disclosed Ownership
15.6M shares
Ownership
49.9%
Form type
SCHEDULE 13D/A
Date filed
3/28/2025, 04:50 PM
Date of event
Mar 26, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
SUVRETTA CAPITAL MANAGEMENT, LLC 49.9% 15.6M 0 15.6M /s/ Andrew Nathanson SUVRETTA CAPITAL MANAGEMENT, LLC 0001569064
Averill Master Fund, Ltd. 44.47% 13.9M 0 13.9M /s/ Andrew Nathanson Averill Master Fund, Ltd. 0001939329
Averill Madison Master Fund, Ltd. 5.43% 1.7M 0 1.7M /s/ Andrew Nathanson Averill Madison Master Fund, Ltd. 0002021243
Aaron Cowen 49.9% 15.6M 0 15.6M /s/ Aaron Cowen Aaron Cowen